Clinical Trials Logo

Morphine Adverse Reaction clinical trials

View clinical trials related to Morphine Adverse Reaction.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03035942 Completed - Pruritus Clinical Trials

Quality of Recovery After Dexamethasone, Ondansetron or Placebo Intrathecal Morphine Administration

Start date: January 2, 2017
Phase: Phase 4
Study type: Interventional

The aim of this study is to evaluate not only the occurrence of side effects, but the quality of the recovery (QoR-40 Questionnaire) of patients submitted to spinal anesthesia with administration of low doses (0.1 mg) of intrathecal morphine for the surgical treatment of fractures in one of the lower limbs and who will receive prophylactic ondansetron (4mg), dexamethasone (8mg) or placebo.

NCT ID: NCT01952626 Completed - Clinical trials for Morphine Adverse Reaction

Prevention of Intrathecal Morphine Induced Pruritus: Comparison of Ondansetron and Palonosetron

Start date: April 2013
Phase: N/A
Study type: Interventional

Intrathecal administration of morphine is often used for control of postoperative pain. However, pruritus is one of the most common side effects of intrathecal morphine . Specific serotonin receptor antagonists could be an effective prophylactic treatment of neuraxial opioid-induced pruritus. It was reported that palonosetron is more effective than ondansetron for prevention of postoperative nausea and vomiting. Therefore, the investigators evaluated the efficacy of prophylactic administration of ondansetron and palonosetron for the prevention of intrathecal morphine-induced pruritus.

NCT ID: NCT00890942 Completed - Clinical trials for Morphine Adverse Reaction

Efficacy of Intramuscular Naloxone 0.4mg. in Prophylaxis of Intrathecal Morphine Induced Pruritus After Cesarean Section

Start date: May 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether intramuscular naloxone 0.4mg. is effective in prophylaxis of intrathecal morphine induced pruritus after cesarean section.